Mair P, Mair J, Bleier J, Waldenberger F, Antretter H, Balogh D, Puschendorf B
Department of Anaesthesia, University of Innsbruck School of Medicine, Austria.
Acta Anaesthesiol Scand. 1995 Oct;39(7):960-4. doi: 10.1111/j.1399-6576.1995.tb04205.x.
In experimental animal models reperfusion of ischaemic myocardium causes sequestration of leucocytes within the coronary circulation. Leucocytes contribute to postischaemic myocardial injury by releasing proteolytic enzymes and by generating oxygen free radicals. The aim of this study was to investigate whether leucocytes also contribute to myocardial injury following ischaemia and reperfusion associated with cardioplegic cardiac arrest. Therefore, we studied the release of the proteolytic enzyme elastase and oxygen free radical initiated myocardial lipid peroxidation in coronary sinus blood during reperfusion after cardioplegic cardiac arrest. The elastase-alpha-1-proteinase inhibitor complex and malondialdehyde (a byproduct of myocardial lipid peroxidation) were measured in arterial, central venous and coronary sinus blood samples in 19 patients undergoing elective coronary artery bypass grafting before aortic crossclamping and 1, 5, 10 and 20 m in after aortic declamping. Malondialdehyde concentrations did not increase significantly during the study period, whereas elastase concentrations showed a significant increase during cardiopulmonary bypass in arterial, central venous as well as coronary sinus blood. Neither elastase nor malondialdehyde concentrations in coronary sinus blood differed significantly from arterial or central venous blood at any time point measured. Our data demonstrated increased elastase concentrations during cardiopulmonary bypass, but we did not find enhance intracoronary elastase release or myocardial during cardiopulmonary bypass, but we did not find enhanced intracoronary elastase release or myocardial lipid peroxidation. Our data suggest that patients are sufficiently protected from leucocyte mediated ischaemia reperfusion injury during uncomplicated coronary artery bypass grafting with cardioplegic arrest.
在实验动物模型中,缺血心肌的再灌注会导致白细胞在冠状动脉循环中滞留。白细胞通过释放蛋白水解酶和产生氧自由基,促成缺血后心肌损伤。本研究的目的是调查白细胞是否也在与心脏停搏相关的缺血和再灌注后促成心肌损伤。因此,我们研究了心脏停搏后再灌注期间冠状动脉窦血中蛋白水解酶弹性蛋白酶的释放以及氧自由基引发的心肌脂质过氧化。在19例行择期冠状动脉搭桥术的患者中,于主动脉交叉钳夹前以及主动脉松开后1、5、10和20分钟,分别采集动脉血、中心静脉血和冠状动脉窦血样本,测定弹性蛋白酶-α1-蛋白酶抑制剂复合物和丙二醛(心肌脂质过氧化的一种副产物)。在研究期间,丙二醛浓度未显著增加,而弹性蛋白酶浓度在体外循环期间,在动脉血、中心静脉血以及冠状动脉窦血中均显著升高。在任何测量时间点,冠状动脉窦血中的弹性蛋白酶和丙二醛浓度与动脉血或中心静脉血相比均无显著差异。我们的数据显示体外循环期间弹性蛋白酶浓度升高,但未发现冠状动脉内弹性蛋白酶释放增加或心肌脂质过氧化增强。我们的数据表明,在进行心脏停搏的择期冠状动脉搭桥术过程中,患者受到充分保护,免受白细胞介导的缺血再灌注损伤。